<DOC>
	<DOCNO>NCT00781001</DOCNO>
	<brief_summary>The purpose study determine vaporize cannabis effective analgesic treatment painful diabetic neuropathy .</brief_summary>
	<brief_title>Efficacy Inhaled Cannabis Diabetic Painful Peripheral Neuropathy</brief_title>
	<detailed_description>Neuropathic pain cause insult nervous system account 25-50 % pain clinic visit . Excluding low back pain , diabetic peripheral neuropathy common neuropathic pain syndrome estimate prevalence 600,000 case United States . There 5 medication approve FDA treatment neuropathic pain 2 5 approve treatment diabetic peripheral neuropathy . Currently , desperate need therapeutic agent treatment neuropathic pain . We propose use painful diabetic peripheral neuropathy ( DPN ) patient study efficacy inhale cannabis neuropathic pain . We enroll 20 subject subject act control ; receive placebo three dos inhale aerosolized cannabis ( low , medium , high ) random order separate least two week . Subjects assess reduction pain , change normal sensation , change cognition , effect cannabis experimentally induced pain .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Willing able provide inform consent History diabetes mellitus type 1 type 2 stable glycemia maintain diet stable regimen diabetic therapy least 12 week prior screen Painful diabetic peripheral neuropathy least 6 month prior screen symmetrical onset confirm neurological exam score least 3 investigator section ( physical exam ) MNSI ( Michigan Neuropathy Screening Instrument ) screening . Subject pain rating least 4 11 point Numeric Pain Scale . Patient acceptable enrollment determine Investigator medical history , physical exam finding , 12 lead ECG finding , clinical laboratory test result . HbA1C &lt; 11 % . For female patient , negative urine pregnancy test Active opportunistic infection opportunistic malignancy require acute treatment Current past cannabis abuse/dependence , current psychoactive drug use disorder ( e.g . opioids , methamphetamine , cocaine , alcohol ) Presence significant cardiac pulmonary disease ( e.g. , tuberculosis , asthma ) Pregnancy ascertain selfreport mandatory commercial pregnancy test marijuana placebo consumption condition . Current serious mental illnesse.g . bipolar disorder , schizophrenia , psychotic disorder Other medical condition may lead peripheral neuropathy Females pregnant planning pregnancy . Females child bear potential use reliable mean birth control . Lower extremity amputation toe . Patients must phantom pain amputated toe . Other painful condition pain vascular origin may confound assessment PDN . Subjects unstable blood glucose level ( Fasting &lt; 70mg/dL random blood glucose level &gt; 250 mg/dL )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>neuropathic pain</keyword>
	<keyword>diabetic neuropathy</keyword>
	<keyword>cannabis</keyword>
	<keyword>marijuana</keyword>
</DOC>